Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +24.96%
#3 Nockchain Nockchain +24.66%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +21.17%
#5 Mubarak Mubarak +19.33%
#6 EXOD EXOD +18.93%
#7 Unit Pump Unit Pump +16.04%
#8 Pump.fun Pump.fun +15.99%
#9 Wrapped POL Wrapped POL +14.85%
#10 POL (ex-MATIC) POL (ex-MATIC) +13.79%
Coin of the day
Official Trump Official Trump
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classificação em ações #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Preço da ação
$0.17616661
Última sincronização: 2026-08-21
Valor de mercado
$73.48M
Variação (1 dia)
0.18%
Variação (1 ano)
-37.76%
País
TW
Negociar Mercury Biopharmaceutical Corporation (6932)

Categoria

Healthcare
Receita da Mercury Biopharmaceutical Corporation (6932)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Mercury Biopharmaceutical Corporation, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Mercury Biopharmaceutical Corporation de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN